Skip to main content
Top

2019 | OriginalPaper | Chapter

14. Accelerating Discovery with Cognitive—An Example Cognitive Application for Discovery: Watson for Drug Discovery

Author : Scott Spangler

Published in: Curious2018

Publisher: Springer International Publishing

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

Watson for Drug Discovery (WDD) is a cloud-based, end-to-end scalable platform that helps life science researchers discover new disease pathways, new drug targets, and additional drug indications. It ingests both structured and unstructured content from multiple internal and external heterogeneous sources. It then uses natural language processing and domain-specific ontologies to annotate this content so that the machine can read and understand the content more like the way a domain expert would.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Literature
1.
go back to reference Bakkar N et al. Artificial intelligence in neurodegenerative disease research: Use of Ibm Watson to identify additional rna-binding proteins altered in amyotrophic lateral sclerosis. Acta neuropathol. 2018;135.2:227–47. Bakkar N et al. Artificial intelligence in neurodegenerative disease research: Use of Ibm Watson to identify additional rna-binding proteins altered in amyotrophic lateral sclerosis. Acta neuropathol. 2018;135.2:227–47.
2.
go back to reference Johnston TH et al. Repurposing drugs to treat L-Dopa-induced dyskinesia in Parkinson’s disease. Neuropharmacology (2018). Johnston TH et al. Repurposing drugs to treat L-Dopa-induced dyskinesia in Parkinson’s disease. Neuropharmacology (2018).
3.
go back to reference Spangler S et al. Automated hypothesis generation based on mining scientific literature. In: Proceedings of the 20th ACM SIGKDD international conference on knowledge discovery and data mining. ACM; 2014. Spangler S et al. Automated hypothesis generation based on mining scientific literature. In: Proceedings of the 20th ACM SIGKDD international conference on knowledge discovery and data mining. ACM; 2014.
Metadata
Title
Accelerating Discovery with Cognitive—An Example Cognitive Application for Discovery: Watson for Drug Discovery
Author
Scott Spangler
Copyright Year
2019
DOI
https://doi.org/10.1007/978-3-030-16061-6_14

Premium Partners